Related Experiment Video
Updated: Dec 12, 2025

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
Tumor suppressor miR-33b-5p regulates cellular function and acts a prognostic biomarker in RCC
Guocheng Huang1,2, Yulin Lai1,3, Xiang Pan1,4
1Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Peking University Shenzhen Hospital Shenzhen 518036, Guangdong, P. R. China.
Background:
Renal cell carcinoma (RCC) is a renal parenchyma neoplasm with a 30% recurrence rate even when treated properly. MicroRNAs are noncoding small RNAs that are involved in cellular communication and may participate in cancer development. This study aimed to explore the relationship between miR-33b-5p expression and RCC progression and prognosis.
Method:
RT-qPCR, CCK-8 assay, wound scratch assay, transwell assay and flow cytometry assay were used to evaluate the expression and function of miR-33b-5p in RCC. Additionally, RCC samples and survival data from The Cancer Genome Atlas were used to analyze the prognostic functions of miR-33b-5p.
Results:
miR-33b-5p expression in RCC tissues and cell lines (786-O, ACHN) were found to be significantly downregulated, compared with normal tissues and cell lines (P<0.001). The miR-33b-5p mimic transfected cells showed a slower proliferation rate (P<0.01), while its invasion ability decreased by 38.16% (786-O, P<0.001) and 49.19% (ACHN, P<0.05), compared with the negative control (NC). The migration ability of both RCC lines were found to be as follows: miR-33b-5p inhibitor > NC or NC inhibitor > miR-33b-5p mimic. Additionally, TCGA and RCC samples reveal that low miR-33b-5p expression is related to poor survival outcomes (univariate analysis, P=0.029; multivariate analysis, P=0.024; Kaplan-Meier survival curves, P=0.014). Target genes prediction suggests that miR-33b-5p performs its tumor-suppressive effects and prognostic role through targeting TBX15, SLC12A5, and PTGFRN.
Conclusions:
miR-33b-5p may function as a tumor-suppressive regulator and prognostic biomarker in RCC.
Insights
MicroRNA miR-33b-5p is downregulated in renal cell carcinoma (RCC), inhibiting cancer progression. Low miR-33b-5p expression correlates with poor patient survival, suggesting its potential as a prognostic biomarker.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- Renal cell carcinoma (RCC) recurs in 30% of patients despite treatment.
- MicroRNAs (miRNAs) are key regulators of cellular processes and implicated in cancer.
- Understanding miRNA roles is crucial for improving RCC prognosis.
Purpose of the Study:
- To investigate the expression of miR-33b-5p in RCC.
- To determine the functional role of miR-33b-5p in RCC progression.
- To evaluate miR-33b-5p as a prognostic biomarker for RCC.
Main Methods:
- Quantitative real-time PCR (RT-qPCR) for miRNA expression analysis.
- Cell proliferation, migration, and invasion assays (CCK-8, wound scratch, Transwell).
- Analysis of The Cancer Genome Atlas (TCGA) data for prognostic correlation.
Main Results:
- miR-33b-5p was significantly downregulated in RCC tissues and cell lines.
- Overexpression of miR-33b-5p suppressed RCC cell proliferation, invasion, and migration.
- Low miR-33b-5p expression correlated with poorer patient survival outcomes.
- Predicted target genes include TBX15, SLC12A5, and PTGFRN.
Conclusions:
- miR-33b-5p acts as a tumor suppressor in RCC.
- miR-33b-5p demonstrates potential as a prognostic biomarker for RCC.
Related Concept Videos
Abnormal Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Negative Regulator Molecules
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

